1. Home
  2. SACH vs VNRX Comparison

SACH vs VNRX Comparison

Compare SACH & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sachem Capital Corp.

SACH

Sachem Capital Corp.

HOLD

Current Price

$1.05

Market Cap

48.6M

Sector

Real Estate

ML Signal

HOLD

Logo VolitionRX Limited

VNRX

VolitionRX Limited

HOLD

Current Price

$0.30

Market Cap

40.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SACH
VNRX
Founded
2010
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
48.6M
40.8M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
SACH
VNRX
Price
$1.05
$0.30
Analyst Decision
Hold
Strong Buy
Analyst Count
3
4
Target Price
$2.00
$3.17
AVG Volume (30 Days)
155.8K
2.5M
Earning Date
11-05-2025
11-13-2025
Dividend Yield
19.13%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,906,000.00
$1,472,007.00
Revenue This Year
N/A
$55.33
Revenue Next Year
$1.73
$493.79
P/E Ratio
N/A
N/A
Revenue Growth
N/A
14.48
52 Week Low
$0.80
$0.27
52 Week High
$1.48
$0.94

Technical Indicators

Market Signals
Indicator
SACH
VNRX
Relative Strength Index (RSI) 50.65 37.99
Support Level $1.00 $0.27
Resistance Level $1.08 $0.33
Average True Range (ATR) 0.04 0.03
MACD 0.01 0.00
Stochastic Oscillator 75.00 38.24

Price Performance

Historical Comparison
SACH
VNRX

About SACH Sachem Capital Corp.

Sachem Capital Corp is a real estate investment trust. The company specializes in originating, underwriting, funding, servicing, and managing a portfolio of short-term loans secured by first mortgage liens on real property located in Connecticut. Its primary objective is to grow the loan portfolio while protecting and preserving capital in a manner that provides for attractive risk-adjusted returns to shareholders over the long term through dividends. The company earns majority of its revenue through Interest income from loans.

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

Share on Social Networks: